当前位置: 首页 > 详情页

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

文献详情

资源类型:

收录情况: ◇ SCIE

作者:
机构: [1]Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [2]Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [3]Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [4]Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [5]Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [6]Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98121 USA; [7]Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA; [8]China Med Board, Boston, MA USA; [9]Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [10]Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [11]Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [12]Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [13]Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [14]Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA; [15]Harvard Univ, Boston Childrens Hosp, Boston, MA 02115 USA; [16]Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; [17]Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [18]Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [19]Univ Texas San Antonio, San Antonio, TX USA; [20]Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [21]Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [22]Univ Melbourne, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia; [23]Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [24]Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India; [25]Emory Univ, Sch Publ Hlth, Atlanta, GA USA; [26]Emory Univ, Sch Med, Atlanta, GA USA; [27]St Georges Univ London, London, England; [28]Mayo Clin, Rochester, MN USA; [29]Univ Auckland, Auckland 1, New Zealand; [30]Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia; [31]Yale Univ, New Haven, CT USA; [32]Boston Univ, Sch Med, Boston, MA 02118 USA; [33]Univ Oxford, Clin Trial Serv Unit, Oxford, England; [34]Univ Oxford, Epidemiol Studies Unit, Oxford, England; [35]Kings Coll London, Inst Dent, London WC2R 2LS, England; [36]Kings Coll London, Hosp NHS Trust, London WC2R 2LS, England; [37]Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [38]Queen Mary Univ London, Inst Dent, London, England; [39]Moscow State Univ Med & Dent, Res Inst Transplantol & Artificial Organs, Moscow, Russia; [40]King Fahad Med City, Riyadh, Saudi Arabia; [41]Michigan State Univ, E Lansing, MI 48824 USA; [42]MRC, Epidemiol Unit, Cambridge, England; [43]London Sch Hyg & Trop Med, London WC1, England; [44]Univ Sydney, No Clin Sch, Dept Rheumatol, Sydney, NSW 2006, Australia; [45]Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [46]Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia; [47]Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [48]INSERM, Paris, France; [49]Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [50]Univ New S Wales, Sydney, NSW, Australia; [51]Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [52]Moorfields Eye Hosp, London, England; [53]Univ Cambridge, Cambridge, England; [54]Univ Leicester, Leicester, Leics, England; [55]Flinders Univ S Australia, Adelaide, SA 5001, Australia; [56]Cabrini Inst, Malvern, Vic, Australia; [57]Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [58]Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [59]Texas A&M Univ, College Stn, TX USA; [60]Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [61]Washington Univ, St Louis, MO USA; [62]Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [63]Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [64]Univ Camilo Jose Cela, Villanueva De La Canada, Spain; [65]Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; [66]NIEHS, Res Triangle Pk, NC 27709 USA; [67]Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [68]Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [69]Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [70]Menzies Sch Hlth Res, Darwin, NT, Australia; [71]Natl Hlth Serv, Edinburgh, Midlothian, Scotland; [72]Univ Edinburgh, Edinburgh, Midlothian, Scotland; [73]Univ Witwatersrand, Johannesburg, South Africa; [74]Loyola Univ, Sch Med, Chicago, IL 60611 USA; [75]Wake Forest Univ, Sch Publ Hlth Sci, Winston Salem, NC 27109 USA; [76]Hosp Dr Gustavo N Collado, Puerto Chitre, Panama; [77]Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [78]Univ Calif San Diego, San Diego, CA 92103 USA; [79]Univ Penn, Philadelphia, PA 19104 USA; [80]Bldg & Rd Res Inst, Kumasi, Ghana; [81]MRC Hearing & Commun Grp, Manchester, Lancs, England; [82]Griffith Univ, Sch Dent & Oral Hlth, Brisbane, Qld 4111, Australia; [83]Griffith Univ, Populat & Social Hlth Res Program, Brisbane, Qld 4111, Australia; [84]Denver VA Med Ctr, Denver, VA USA; [85]Univ Otago, Dunedin, New Zealand; [86]Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [87]Univ Peradeniya, Peradeniya, Sri Lanka; [88]Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [89]Hosp Santa Creu & Sant Pau, Barcelona, Spain; [90]Univ Ulster, Ulster, Ireland; [91]Fed Minist Hlth, Khartoum, Sudan; [92]Hosp Maciel, Montevideo, Uruguay; [93]Emerald Publ Hlth Consulting Serv Ltd, Abuja, Nigeria; [94]Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [95]Auckland Tech Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [96]Univ Fed Sao Paulo, Sch Med, Sao Paulo, Brazil; [97]Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [98]James Cook Univ, Townsville, Qld 4811, Australia; [99]Howard Univ, Coll Med, Washington, DC USA; [100]Addict Info Switzerland, Lausanne, Switzerland; [101]Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [102]Suny Downstate Med Ctr, Coll Med, Brooklyn, NY 11203 USA; [103]Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [104]Univ Lorraine, Nancy, France; [105]Univ Bristol, Bristol, Avon, England; [106]NYU, New York, NY USA; [107]Brandeis Univ, Waltham, MA USA; [108]Univ Barcelona, CIBERSAM, St Boi De Llobregat, Spain; [109]Karolinska Univ Hosp, Stockholm, Sweden; [110]Queen Elizabeth Hosp, Adelaide, SA, Australia; [111]Univ Franche Comte, F-25030 Besancon, France; [112]Ctr Hosp Reg Univ Besancon, Besancon, France; [113]NIDCD, NIH, Bethesda, MD USA; [114]NIDDK, NIH, Bethesda, MD USA; [115]Baylor Coll Med, Natl Sch Trop Med, Waco, TX USA; [116]Univ Port Harcourt, Port Harcourt, Nigeria; [117]George Mason Univ, Fairfax, VA 22030 USA; [118]Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [119]All India Inst Med Sci, New Delhi, India; [120]Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cardiol, IL-91010 Jerusalem, Israel; [121]Case Western Reserve Univ, Cleveland, OH 44106 USA; [122]Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [123]Univ S Africa, Johannesburg, South Africa; [124]Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [125]Univ Tasmania, Hobart, Tas 7001, Australia; [126]Nova SE Univ, Ft Lauderdale, FL 33314 USA; [127]Minist Hlth, Jerusalem, Israel; [128]Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [129]Swansea Univ, Swansea, W Glam, Wales; [130]Mulago Hosp, Kampala, Uganda; [131]Asian Pacific Soc Cardiol, Kyoto, Japan; [132]MRC, Tygerberg, South Africa; [133]Univ Cape Town, Hatter Inst, ZA-7925 Cape Town, South Africa; [134]Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [135]Legacy Hlth Syst, Portland, OR USA; [136]Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [137]Natl Inst Psychiat Ramon de la Fuente, Mexico City, DF, Mexico; [138]Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [139]Pacific Inst Res & Evaluat, Calverton, MD USA; [140]Natl Inst Hlth, Maputo, Mozambique; [141]Univ Eduardo Mondlane, Maputo, Mozambique; [142]Duke Univ, Durham, NC USA; [143]IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [144]Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [145]Queensland Univ Technol, Brisbane, Qld 4001, Australia; [146]Natl Ctr Child Hlth & Dev, Tokyo, Japan; [147]Watford Dist Gen Hosp, Watford, England; [148]Kemri Wellcome Trust, Kilifi, Kenya; [149]Univ KwaZulu Natal, AVRI, Durban, South Africa; [150]Ctr Studi GISED, Bergamo, Italy; [151]Charite, D-13353 Berlin, Germany; [152]Natl Univ Ireland Galway, HRB Clin Res Facil, Galway, Ireland; [153]Deakin Univ, Melbourne, Vic, Australia; [154]BP Koirala Inst Hlth Sci, Dharan, Nepal; [155]Betty Cowan Res & Innovat Ctr, Ludhiana, Punjab, India; [156]Hosp Joan 23, La Paz, Bolivia; [157]Univ Calgary, Calgary, AB, Canada; [158]Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [159]Hosp Univ Cruces, Baracaldo, Spain; [160]Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China; [161]Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [162]Brigham Young Univ, Provo, UT 84602 USA; [163]Ctr Addict & Mental Hlth, Toronto, ON, Canada; [164]Hosp Univ Canarias, Tenerif, Spain; [165]Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [166]Vector Control Res Ctr, Pondicherry, India; [167]Ctr Dis Anal, Louisville, CO USA; [168]Univ Calif Berkeley, Berkeley, CA 94720 USA; [169]Univ Chicago, NORC, Chicago, IL 60637 USA; [170]Complejo Hosp Caja Seguro Social, Panama City, Panama; [171]Turning Point Alcohol & Drug Ctr, Ctr Alcohol Policy Res, Fitzroy, SA, Australia; [172]Vanderbilt Univ, Nashville, TN USA; [173]Univ Alabama Birmingham, Birmingham, AL USA; [174]Minist Interior, Madrid, Spain; [175]Hlth Canada, Ottawa, ON K1A 0L2, Canada; [176]Queens Med Ctr, Honolulu, HI USA; [177]Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [178]Aga Khan Univ, Karachi, Pakistan; [179]Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [180]Univ Alberta, Alberta Kidney Dis Network, Edmonton, AB, Canada; [181]Cincinnati Childrens Hosp, Cincinnati, OH USA; [182]Copenhagen Univ Hosp, Dept Neurol, Herlev, Denmark; [183]Univ Crete, Sch Med, Iraklion, Greece; [184]ANLIS, Inst Nacl Epidemiol, Malbran, Argentina; [185]KNCV TB Fdn, The Hague, Netherlands; [186]Maastricht Univ, Med Ctr, Maastricht, Netherlands; [187]Natl Univ Singapore, Singapore 117548, Singapore; [188]Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [189]Brown Univ, Providence, RI 02912 USA; [190]Royal Childrens Hosp, Melbourne, Vic, Australia; [191]Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [192]Univ Nottingham, Nottingham NG7 2RD, England; [193]Hollywood Orthopaed Grp, Perth, WA, Australia; [194]Arthrit Res, Wichita, KS USA; [195]Royal Cornwall Hosp, Truro, England; [196]London Sch Econ, London WC2A 2AE, England; [197]Landstuhl Reg Med Ctr, Landstuhl, Germany; [198]Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA
出处:
ISSN:

摘要:
Background Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. The 1990 Global Burden of Disease study proposed disability-adjusted life years (DALYs) to measure disease burden. No comprehensive update of disease burden worldwide incorporating a systematic reassessment of disease and injury-specific epidemiology has been done since the 1990 study. We aimed to calculate disease burden worldwide and for 21 regions for 1990, 2005, and 2010 with methods to enable meaningful comparisons over time. Methods We calculated DALYs as the sum of years of life lost (YLLs) and years lived with disability (YLDs). DALYs were calculated for 291 causes, 20 age groups, both sexes, and for 187 countries, and aggregated to regional and global estimates of disease burden for three points in time with strictly comparable definitions and methods. YLLs were calculated from age-sex-country-time-specific estimates of mortality by cause, with death by standardised lost life expectancy at each age. YLDs were calculated as prevalence of 1160 disabling sequelae, by age, sex, and cause, and weighted by new disability weights for each health state. Neither YLLs nor YLDs were age-weighted or discounted. Uncertainty around cause-specific DALYs was calculated incorporating uncertainty in levels of all-cause mortality, cause-specific mortality, prevalence, and disability weights. Findings Global DALYs remained stable from 1990 (2.503 billion) to 2010 (2.490 billion). Crude DALYs per 1000 decreased by 23% (472 per 1000 to 361 per 1000). An important shift has occurred in DALY composition with the contribution of deaths and disability among children (younger than 5 years of age) declining from 41% of global DALYs in 1990 to 25% in 2010. YLLs typically account for about half of disease burden in more developed regions (high-income Asia Pacific, western Europe, high-income North America, and Australasia), rising to over 80% of DALYs in sub-Saharan Africa. In 1990, 47% of DALYs worldwide were from communicable, maternal, neonatal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries. By 2010, this had shifted to 35%, 54%, and 11%, respectively. Ischaemic heart disease was the leading cause of DALYs worldwide in 2010 (up from fourth rank in 1990, increasing by 29%), followed by lower respiratory infections (top rank in 1990; 44% decline in DALYs), stroke (fifth in 1990; 19% increase), diarrhoeal diseases (second in 1990; 51% decrease), and HIV/AIDS (33rd in 1990; 351% increase). Major depressive disorder increased from 15th to 11th rank (37% increase) and road injury from 12th to 10th rank (34% increase). Substantial heterogeneity exists in rankings of leading causes of disease burden among regions. Interpretation Global disease burden has continued to shift away from communicable to non-communicable diseases and from premature death to years lived with disability. In sub-Saharan Africa, however, many communicable, maternal, neonatal, and nutritional disorders remain the dominant causes of disease burden. The rising burden from mental and behavioural disorders, musculoskeletal disorders, and diabetes will impose new challenges on health systems. Regional heterogeneity highlights the importance of understanding local burden of disease and setting goals and targets for the post-2015 agenda taking such patterns into account. Because of improved definitions, methods, and data, these results for 1990 and 2010 supersede all previously published Global Burden of Disease results.

基金:
语种:
高被引:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2011]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
JCR分区:
出版当年[2010]版:
Q1 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2010版] 出版当年五年平均 出版前一年[2009版] 出版后一年[2011版]

第一作者:
第一作者机构: [5]Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA;
通讯作者:
通讯机构: [5]Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [198]Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院